XPhyto Therapeutics Commences Trading on the Frankfurt Stock Exchange
Vancouver, British Columbia--(Newsfile Corp. - August 13, 2019) - XPhyto Therapeutics Corp. (CSE: XPHY) ("XPhyto" or the "Company") is pleased to announce that its common shares have commenced trading today on the Frankfurt Stock Exchange (the "FSE") under the ticker symbol "4XT"."Given XPhyto's German cannabis licence and its commitment to building import and distribution capability in the country, a Frankfurt listing was a logical choice," noted Hugh Rogers, CEO of XPhyto. "We are excited...
2019-08-13 11:52 AM EDT
XPhyto Therapeutics Commences Trading on the CSE
Vancouver, British Columbia--(Newsfile Corp. - August 6, 2019) - XPhyto Therapeutics Corp. (CSE: XPHY) ("XPhyto" or the "Company") is pleased to announce that its common shares will commence trading today on the Canadian Securities Exchange (the "CSE") under the ticker symbol "XPHY"."Trading on the CSE is a significant corporate milestone on our way to becoming a major player in the next wave of cannabis investment opportunities," said Hugh Rogers, CEO of XPhyto. "With XPhyto's recently...
2019-08-06 8:30 AM EDT
XPhyto Therapeutics Receives German Cannabis Licence for Scientific Cultivation and Extraction
Vancouver, British Columbia--(Newsfile Corp. - July 24, 2019) - XPhyto Therapeutics Corp. ("XPhyto" or the "Company") is pleased to announce that the German Federal Institute for Drugs and Medical Devices ("BfArM") has granted XPhyto's wholly owned German subsidiary, Bunker Pflanzenextrakte GmbH ("Bunker"), a cannabis cultivation and extraction licence for scientific purposes (the "Licence"). Subject to meeting BfArM security requirements, the Licence is valid and authorizes the Company to...
2019-07-24 6:00 AM EDT